Effects of noradrenaline and N6,O2'-dibutyryl 3',5'-cyclic AMP on adipocyte glycerolipid-synthesizing enzymes.
D000217:Acyltransferases / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D003567:Cytidine Diphosphate Diglycerides / Q000378:metabolism; D002798:Diacylglycerol Cholinephosphotransferase / Q000378:metabolism; D051048:Diacylglycerol O-Acyltransferase; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D009713:Nucleotidyltransferases / Q000378:metabolism; D010711:Phosphatidate Phosphatase / Q000378:metabolism; D051381:Rats
D003567:Cytidine Diphosphate Diglycerides; D007328:Insulin; D003994:Bucladesine; D000217:Acyltransferases; D051048:Diacylglycerol O-Acyltransferase; D009713:Nucleotidyltransferases; C022348:phosphatidate cytidylyltransferase; D002798:Diacylglycerol Cholinephosphotransferase; D010711:Phosphatidate Phosphatase; D009638:Norepinephrine